Regeneron Pharmaceuticals, Inc. (REGN) NASDAQ

652.91

-1.57(-0.24%)

Updated at October 29 04:00PM

Currency In USD

Valuation

Market Cap76.86B
Enterprise Value77.31B
P/E Ratio14.9
PEG Ratio3.68
Price/Sales Ratio4.81
Price/Book Ratio2.2
Enterprise/Revenue4.83
Enterprise/EBITDA12.35

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.32
Operating Margin0.26

Management Effectiveness

Return On Assets0.11
Return On Equity0.15

Income Statement

Revenue14.2B
Revenue/Share137.5
Gross Profit12.23B
EBITDA5.32B
Net Income4.41B
Diluted EPS38.34

Balance Sheet

Total Cash8.44B
Total Cash/Share81.49
Total Debt2.71B
Total Debt/Equity0.09
Current Ratio4.06
Book Value Per Share298.76

Price History

52-Week Change-28.95
52-Week High935.86
52-Week Low476.49
Moving Average 50 Days578.02
Moving Average 200 Days597.03

Statistics

Average Volume1.06M
Shares Outstanding104.17M
% Held by Institutions80.79

Dividend And Splits

Trailing Annual Dividend Rate2.64
Trailing Annual Dividend Yield0.4
Payout Ratio0.06
Last Split FactorN/A
Last Split DateN/A